Health Care · VRTX
Vertex Pharmaceuticals
The joined public record for Vertex Pharmaceuticals in the CompanyClues 2026-09-01 release: 4,465 verified records across 4 sources, most recently active 2026-08-31.
Joined records by source
| Source | Records | Last 365 days | Last 90 days | Last 30 days | Most recent |
|---|---|---|---|---|---|
| SEC EDGAR submissions and XBRL company facts U.S. Securities and Exchange Commission | 3,640 | 200 | 24 | 4 | 2026-08-31 |
| Lobbying Disclosure Act filings U.S. Senate and U.S. House of Representatives | 525 | 62 | 18 | 4 | 2026-08-03 |
| ClinicalTrials.gov study records U.S. National Library of Medicine | 288 | 17 | 5 | 2 | 2026-08-31 |
| EPA ECHO facility compliance summaries U.S. Environmental Protection Agency | 12 | 3 | 3 | 0 | 2026-06-16 |
Counts are the release totals as of 2026-09-01. All nine per-company source checks completed for VRTX in this release. Records matched below the 0.90 confidence bar are held out of these counts. Federal Register matches for this company sit in that review queue and are not counted here.
Get the full record for Vertex Pharmaceuticals
This page is the summary. The paid Activity Events dataset holds every row behind these counts for all 500 companies, with dates, amounts, matched names, confidence scores, and source links; the SEC Facts dataset holds 12,725,813 XBRL facts with filing context.
See the datasets Buy on companyclues.com Look up another ticker